I believe that one of the most important reasons that clinicians don't
find guidelines usable or useful is that they are almost never coherent
or internally consistent.
Another critical problem is that they can be counted on to recite what
everyone knows and then to punt on every difficult point--"clinical
judgment recommended".
Jim
James M. Walker, MD, FACP
Chief Health Information Officer
Geisinger Health System
>>> "Shaikh, Javed (Capita India)" <[log in to unmask]>
2/10/2011 4:27 AM >>>
Thanks, Felice. I do agree with your valuable thoughts.
I came across this topic while reading a book on clinical guidelines.
Available at: http://www.nap.edu/catalog.php?record_id=1863
Many thanks
Best Regards
Javed
From: Felice Musicco (IFO) [mailto:[log in to unmask]]
Sent: Thursday, February 10, 2011 2:52 PM
To: Shaikh, Javed (Capita India); [log in to unmask]
Subject: R: WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?
Hi Javed,
i can tell you that usually clinicians are not "in love" with
guidelines for a lot of reasons. You can find in this list a lot of
email about the topic. Sometime guidelines are considered as limitations
for EBM at POC for patient.
However policy makers should go on this for concerns about quality of
care, variability in use of drugs for the same clinical problem, risk.
EB guideline in use can cause costs reduction but sometime costs are
increased (direct cost, drug, devices..). Sure you have applied evidence
based health care principles. These should be a way to evaluate
assistance and real health care among different hospitals. Patients
should be trained about the value of guideline in use in HC settings.
Felice
_______________________________________________________
Dr. Felice Musicco
Hospital Pharmacist
Resp. Servizio FarmED, Farmacovigilanza, Registri AIFA
Istituti Fisioterapici Ospitalieri, Roma
tel +39 06 5266.2989-2047
fax +39 06 52662850
email [log in to unmask]
[log in to unmask]
www.ifo.it
Da: Evidence based health (EBH)
[mailto:[log in to unmask]] Per conto di Shaikh,
Javed (Capita India)
Inviato: mercoledì 9 febbraio 2011 11:49
A: [log in to unmask]
Oggetto: WHY ARE POLICY MAKERS INTERESTED IN GUIDELINES?
Dear All,
I was going through the topic of clinical guidelines and their
relevance with policy makers. Would like to hear thoughts from the
group.
Some excerpts:
Some would explain the interest in practice guidelines shown by
legislators, regulators, and purchasers of health care (as contrasted
with practitioners and patients) with a single phrase: out-of-control
health care costs. Although the importance of costs as a stimulus for
guidelines should not be understated, concerns about quality of care,
risk management, and improved patient outcomes also figure prominently
in the call for more and better practice guidelines....
Scientific evidence and clinical judgment can be systematically
combined to produce clinically valid, operational recommendations for
appropriate care that can and will be used to persuade clinicians,
patients, and others to change their practices in ways that lead to
better health outcomes and lower health care costs.
Thanks and Regards
Javed
.............................................................................
Javed Shaikh, M.S.(Pharm)
This email and any attachment to it are confidential. Unless you are
the intended recipient, you may not use, copy or disclose either the
message or any information contained in the message. If you are not the
intended recipient, you should delete this email and notify the sender
immediately.
Any views or opinions expressed in this email are those of the sender
only, unless otherwise stated. All copyright in any Capita material in
this email is reserved.
All emails, incoming and outgoing, may be recorded by Capita and
monitored for legitimate business purposes.
Capita exclude all liability for any loss or damage arising or
resulting from the receipt, use or transmission of this email to the
fullest extent permitted by law.
Click here
<https://www.mailcontrol.com/sr/Aqb4Ztpp6U7TndxI!oX7UseyfNgsFvsQyQSB7zdsicfW75fjMCuenvgueKnV1gyEbfShgGCNT+J+s7xSCXkZmg==>
to report this email as spam.
This email has been scanned for all viruses by the MessageLabs SkyScan
service.
This email and any attachment to it are confidential. Unless you are
the intended recipient, you may not use, copy or disclose either the
message or any information contained in the message. If you are not the
intended recipient, you should delete this email and notify the sender
immediately.
Any views or opinions expressed in this email are those of the sender
only, unless otherwise stated. All copyright in any Capita material in
this email is reserved.
All emails, incoming and outgoing, may be recorded by Capita and
monitored for legitimate business purposes.
Capita exclude all liability for any loss or damage arising or
resulting from the receipt, use or transmission of this email to the
fullest extent permitted by law.
IMPORTANT WARNING: The information in this message (and the documents attached to it, if any) is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken, or omitted to be taken, in reliance on it is prohibited and may be unlawful. If you have received this message in error, please delete all electronic copies of this message (and the documents attached to it, if any), destroy any hard copies you may have created and notify me immediately by replying to this email. Thank you.
|